Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
TRESU Investment Holding A/S – Announcement of Q1 2024 Interim Report
-
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
-
COUNSLR EXPANDS INTO RHODE ISLAND, PARTNERING WITH BRISTOL WARREN REGIONAL SCHOOL DISTRICT TO INCREASE ACCESS TO MENTAL HEALTH SUPPORT SERVICES
-
Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome
-
Questex Unveils Hotel Management’s Tête-à-Tech: Elevating Curated Connections at The Annual Hospitality Conference and HTNG Connect: Europe
-
Ecliptic Technology and Bottomline Redefine Global Expert Management for Insurers
-
Captain T Cell Secures Seed Financing Round Totaling € 8.5 Million
-
Philips ePatch and AI analytics platform rolled out to 14 hospitals across Spain to monitor heart patients
-
Mandatory Notification of Trade
-
Photocat A/S announces a 3-years Partnership and License Agreement with Prefabricados Ponce S.L. to combat NOx pollution in Spain.
-
Form 8.5 (EPT/RI) - Trinity Exploration & Production Plc
-
Elevate Your Fitness Experience with freebeat's Revolutionary AI Technology
-
Elevate Your Fitness Experience with freebeat's Revolutionary AI Technology
-
Form 8.5 (EPT/RI) - FireAngel Safety Technology Group Plc
-
Form 8.5 (EPT/RI) - musicMagpie Plc
-
LIFT intersects 35 m at 1.32% Li2O at its Shorty pegmatite, Yellowknife Lithium Project, NWT
-
Andes Technology and Arteris Partner To Accelerate RISC-V SoC Adoption
-
Hexagon Purus to supply Toyota Motor North America for serial production of heavy-duty fuel cell electric powertrain kits
-
$MAO Announces its Bid for “Memecoin of 2024,” Advancing the $DOGE and $SHIB Legacy
-
Hexagon Purus to supply Toyota Motor North America for serial production of heavy-duty fuel cell electric powertrain kits
-
deepull appoints Didier Deltort to its Board of Directors
-
Copenhagen Infrastructure Partners inaugurates the Changfang-Xidao offshore wind farms in Taiwan
-
Municipality Finance issues a EUR 50 million tap under its MTN programme
-
LACROIX announces the transfer of its Street Lighting segment to the Environment activity and the project to sell its CITY - Mobility segment (Traffic and V2X).
-
HKQAA upgrades Guotai Junan International's sustainable development rating to BBB+
-
HKQAA upgrades Guotai Junan International's sustainable development rating to BBB+
-
Moody’s Ratings affirms Šiaulių Bankas’ ratings and its stable outlook
-
Participation Notification by BlackRock Inc.
-
Lleida.net sales increase 7% in the first 4 months of 2024, up to 6.3 million euros
-
Issue of additional 2.99 MEUR Green Bonds issue of UAB "Atsinaujinančios energetikos investicijos"
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Cornish Metals Increases Land Ownership at South Crofty Tin Project
-
Arbutus to Present Imdusiran Data at EASL Congress 2024
-
NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update
-
Equinor ASA: Share buy-back
-
GOGL – First Quarter 2024 Results
-
GTT: Terms of availability of preparatory documents for the combined general meeting of shareholders on June 12, 2024
-
Transaction in own shares
-
KBC Group: Update regarding the KBC Group share buyback programme
-
A Report on the Topics to be Covered in the Webinar
-
Novaturas Group earned EUR 34.5 mln. in the first quarter
-
Novaturas Group earned EUR 34.5 mln. in the first quarter
-
Transaction in Own Shares
-
Nextensa offers its shareholders an optional dividend
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases
-
Aalberts N.V.: Aalberts sustained added value margin in challenging market environment
-
Trial carbon capture unit begins operating on Blast Furnace at ArcelorMittal Gent, Belgium
-
Press news: Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump®

